医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mevion Joins Partnership to Open the First Children’s Proton Center in China

2021年03月11日 PM09:00
このエントリーをはてなブックマークに追加


 

LITTLETON, Mass.

Mevion Medical Systems announced today that it has signed a partnership agreement with Children’s Hospital of Fudan University in Shanghai and Shanghai Fosun Healthcare (Group) Co., Ltd. to establish the first pediatric proton therapy center in China. Under the agreement, the three parties will collaborate on the proton therapy center’s development, clinical services, training, and research activities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210311005291/en/

The signing ceremony at Children’s Hospital of Fudan University in Shanghai (Photo: Business Wire)

The signing ceremony at Children’s Hospital of Fudan University in Shanghai (Photo: Business Wire)

As an advanced form of radiation therapy, proton therapy can reduce unnecessary radiation dose to healthy tissue and prevents complications and secondary cancers. These advantages are especially beneficial for pediatric cancer patients, whose bodies are still growing and developing and are more susceptible to these adverse events.

According to GLOBALCON 2020, the estimated number of new pediatric cancer patients in China last year was 36,651. However, the lack of operating proton centers and specialized medical professionals has significantly limited Chinese pediatric patients’ access to proton therapy.

“This joint collaboration represents a significant milestone for Mevion and pediatric patients in China. By providing the first pediatric hospital in China with direct access to proton therapy, together we embark on a new era of patient care that will provide our life-changing technology to children and their families”, said Tina Yu, chief executive officer of Mevion Medical Systems. “We are proud to continue to fulfill our mission to provide accessible proton therapy to every corner of the globe.”

Joining the event was Grace Eline, a 12-year-old cancer survivor who underwent proton therapy at Robert Wood Johnson University Hospitals Laurie Proton Therapy Center, and Stephanie Perkins, M.D., director of the Kling Proton Therapy Center at Siteman Cancer Center, Barnes-Jewish Hospital at Washington University, St. Louis, MO. Both guests emphasized the need to increase access to proton therapy to the pediatric population.

The new proton therapy center will be located at StarKids Children’s Hospital Shanghai, on the New Hong Qiao campus of Children’s Hospital of Fudan University. Founded in 1952, the Children’s Hospital of Fudan University is one of the top children’s hospitals in China, leading in clinical services, teaching, and research.

About Mevion Medical Systems

Since 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion was the first company to innovate this new single-room platform and continues to further the science and application of proton therapy. Mevion’s flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the world’s smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems. Mevion is headquartered in Littleton, Massachusetts, with a presence in Europe and Asia.

Follow us on Twitter: @MevionMedical
Connect with us on LinkedIn: Mevion Medical Systems
Like Us on Facebook: MevionMedical

View source version on businesswire.com: https://www.businesswire.com/news/home/20210311005291/en/

CONTACT

Melanie Benton

Director, Marketing

mbenton@mevion.com

1.978.540.1551

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • GC Pharma Lights Up to Celebrate ‘World Hemophilia Day’
  • ノクソファームが敗血症性ショック治療の効用でビヨンダの特許を出願
  • 东阳光药选择ABEC大型发酵罐以提高生物制药生产能力
  • Aural Analytics, Inc. and Healint, Pte. Ltd. Partner on Integration of Speech Analytics into Healint’s Suite of Clinical Trials and Widely Used Consumer Applications
  • Anji Pharma Adds Clinical Sites to Accelerate Clinical Development of Pradigastat for the Treatment of Functional Constipation